RESISTANCE TO OXAMNIQUINE OF A Schistosoma mansoni STRAIN ISOLATED FROM PATIENT SUBMITTED TO REPEATED TREATMENTS

A strain of Schistosoma mansoni (R1) was isolated from patient previously submitted to four treatments with oxamniquine, and to another one with praziquantel. The results obtained with chemotherapeutic test, by using oxamniquine in mice infected with the strains R1 and LE (standard), showed an evide...

Full description

Bibliographic Details
Main Authors: M.Z. COELHO, F.C. LIMA E SILVA, J.A. NOGUEIRA-MACHADO
Format: Article
Language:English
Published: Universidade de São Paulo 1997-03-01
Series:Revista do Instituto de Medicina Tropical de São Paulo
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651997000200007
id doaj-2858117099a74ac1a8229bd9902c87d1
record_format Article
spelling doaj-2858117099a74ac1a8229bd9902c87d12020-11-25T00:59:48ZengUniversidade de São PauloRevista do Instituto de Medicina Tropical de São Paulo0036-46651678-99461997-03-0139210110.1590/S0036-46651997000200007RESISTANCE TO OXAMNIQUINE OF A Schistosoma mansoni STRAIN ISOLATED FROM PATIENT SUBMITTED TO REPEATED TREATMENTSM.Z. COELHOF.C. LIMA E SILVAJ.A. NOGUEIRA-MACHADOA strain of Schistosoma mansoni (R1) was isolated from patient previously submitted to four treatments with oxamniquine, and to another one with praziquantel. The results obtained with chemotherapeutic test, by using oxamniquine in mice infected with the strains R1 and LE (standard), showed an evident resistance to the drug in worms of the strain R1. Thus, at the dose of 250 mg/kg oxamniquine, all mice (17) infected with the LE strain did not show surviving worms, whereas 12 out of 17 mice infected with the R1 strain presented surviving worms. At the dose of 200 mg/kg, the LE strain showed recovery rates of 1.06% and 20.58%, whereas the R1 strain presented 18.57% and 61.14%, for male and female worms, respectively. At the dose of 100 mg/kg, the recovery of male worms was 2.6% for the LE strain, and 29.9% for the R1 strain. At the same dose, the recovery of females did not show statistically significant differences between the two strains (LE = 76.38%, R1 = 79.12%). Praziquantel showed similar antischistosomal activity against both studied strains, when administered at the dose of 500 mg/kg<br>Resistência ao oxamniquine de uma cepa de Schistosoma mansoni isolada de paciente submetido a repetidos tratamentos Uma cepa de Schistosoma mansoni (R1) foi isolada de paciente previamente submetido a quatro tratamentos com oxamniquine e a um outro com praziquantel. Os resultados obtidos com o teste quimioterapêutico, usando oxamniquine em camundongos infectados com as cepas R1 e LE (padrão) mostraram resistência evidente à droga em vermes de cepa R1. Assim, com a dose de 250 mg/kg de oxamniquine, todos os camundongos (17) dos 17 camundongos infectados com a cepa R1 apresentaram vermes sobreviventes. Com a dosagem de 200 mg/kg a cepa LE mostrou taxas de recuperação de 1,06 e 20,58% enquanto a cepa R1 apresentou 18,57 e 61,14% para os vermes machos e fêmeas, respectivamente. Com a dose de 100 mg/kg a recuperação de vermes machos foi de 2,6% para a Cepa LE e 29,9% para a R1. Com a mesma dosagem, a recuperação de fêmeas não mostrou diferenças estatisticamente significantes entre as duas espécies (LE = 76,38%, R1 = 79,12%). Praziquantel mostrou atividade-esquistossomicida semelhante contra ambas cepas estudadas quando administrado na dosagem de 500 mg/kghttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651997000200007Schistosoma mansonidrug resistanceoxamniquinepraziquantel
collection DOAJ
language English
format Article
sources DOAJ
author M.Z. COELHO
F.C. LIMA E SILVA
J.A. NOGUEIRA-MACHADO
spellingShingle M.Z. COELHO
F.C. LIMA E SILVA
J.A. NOGUEIRA-MACHADO
RESISTANCE TO OXAMNIQUINE OF A Schistosoma mansoni STRAIN ISOLATED FROM PATIENT SUBMITTED TO REPEATED TREATMENTS
Revista do Instituto de Medicina Tropical de São Paulo
Schistosoma mansoni
drug resistance
oxamniquine
praziquantel
author_facet M.Z. COELHO
F.C. LIMA E SILVA
J.A. NOGUEIRA-MACHADO
author_sort M.Z. COELHO
title RESISTANCE TO OXAMNIQUINE OF A Schistosoma mansoni STRAIN ISOLATED FROM PATIENT SUBMITTED TO REPEATED TREATMENTS
title_short RESISTANCE TO OXAMNIQUINE OF A Schistosoma mansoni STRAIN ISOLATED FROM PATIENT SUBMITTED TO REPEATED TREATMENTS
title_full RESISTANCE TO OXAMNIQUINE OF A Schistosoma mansoni STRAIN ISOLATED FROM PATIENT SUBMITTED TO REPEATED TREATMENTS
title_fullStr RESISTANCE TO OXAMNIQUINE OF A Schistosoma mansoni STRAIN ISOLATED FROM PATIENT SUBMITTED TO REPEATED TREATMENTS
title_full_unstemmed RESISTANCE TO OXAMNIQUINE OF A Schistosoma mansoni STRAIN ISOLATED FROM PATIENT SUBMITTED TO REPEATED TREATMENTS
title_sort resistance to oxamniquine of a schistosoma mansoni strain isolated from patient submitted to repeated treatments
publisher Universidade de São Paulo
series Revista do Instituto de Medicina Tropical de São Paulo
issn 0036-4665
1678-9946
publishDate 1997-03-01
description A strain of Schistosoma mansoni (R1) was isolated from patient previously submitted to four treatments with oxamniquine, and to another one with praziquantel. The results obtained with chemotherapeutic test, by using oxamniquine in mice infected with the strains R1 and LE (standard), showed an evident resistance to the drug in worms of the strain R1. Thus, at the dose of 250 mg/kg oxamniquine, all mice (17) infected with the LE strain did not show surviving worms, whereas 12 out of 17 mice infected with the R1 strain presented surviving worms. At the dose of 200 mg/kg, the LE strain showed recovery rates of 1.06% and 20.58%, whereas the R1 strain presented 18.57% and 61.14%, for male and female worms, respectively. At the dose of 100 mg/kg, the recovery of male worms was 2.6% for the LE strain, and 29.9% for the R1 strain. At the same dose, the recovery of females did not show statistically significant differences between the two strains (LE = 76.38%, R1 = 79.12%). Praziquantel showed similar antischistosomal activity against both studied strains, when administered at the dose of 500 mg/kg<br>Resistência ao oxamniquine de uma cepa de Schistosoma mansoni isolada de paciente submetido a repetidos tratamentos Uma cepa de Schistosoma mansoni (R1) foi isolada de paciente previamente submetido a quatro tratamentos com oxamniquine e a um outro com praziquantel. Os resultados obtidos com o teste quimioterapêutico, usando oxamniquine em camundongos infectados com as cepas R1 e LE (padrão) mostraram resistência evidente à droga em vermes de cepa R1. Assim, com a dose de 250 mg/kg de oxamniquine, todos os camundongos (17) dos 17 camundongos infectados com a cepa R1 apresentaram vermes sobreviventes. Com a dosagem de 200 mg/kg a cepa LE mostrou taxas de recuperação de 1,06 e 20,58% enquanto a cepa R1 apresentou 18,57 e 61,14% para os vermes machos e fêmeas, respectivamente. Com a dose de 100 mg/kg a recuperação de vermes machos foi de 2,6% para a Cepa LE e 29,9% para a R1. Com a mesma dosagem, a recuperação de fêmeas não mostrou diferenças estatisticamente significantes entre as duas espécies (LE = 76,38%, R1 = 79,12%). Praziquantel mostrou atividade-esquistossomicida semelhante contra ambas cepas estudadas quando administrado na dosagem de 500 mg/kg
topic Schistosoma mansoni
drug resistance
oxamniquine
praziquantel
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651997000200007
work_keys_str_mv AT mzcoelho resistancetooxamniquineofaschistosomamansonistrainisolatedfrompatientsubmittedtorepeatedtreatments
AT fclimaesilva resistancetooxamniquineofaschistosomamansonistrainisolatedfrompatientsubmittedtorepeatedtreatments
AT janogueiramachado resistancetooxamniquineofaschistosomamansonistrainisolatedfrompatientsubmittedtorepeatedtreatments
_version_ 1725216089307086848